Role of Presenilin1 and Beta-Catenin Interaction In Vivo
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000019
Summary
The PS1 gene is expressed throughout the bodies of all mammals. The complete loss of the PS1 gene in laboratory mice causes a lethal condition in mouse embryos. However, specialized mouse strains that have been engineered to express the human PS1 in the central nervous system, but not elsewhere, can survive. Dr. Zheng has found that these mice develop epidermal hyperplasia and neoplasm, or skin cancer, and that the skin cancer phenotype is similar to that found for transgenic mice that exhibit overactivity in the molecule Beta-Catenin. Dr. Zheng has proposed that this molecule interacts with PS1 and plays a role in cell signaling. In this study, she is attempting to determine the molecular mechanisms of PS1 in the growth of tumors. Then the discovery will be utilized to generate specific mutations in PS1 to further examine its interaction with Beta-Catenin. Because this technique allows the survival of mice whose expression of PS1 has been inhibited, it is hoped that a better understanding of the role of PS-1 in adult tissues will be attained.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University